Cipher Pharmaceuticals Inc CPHRF:OTCQX

*Data is delayed | Exchange | USD
Last | 04/24/24 EDT
6.23quote price arrow down-0.27 (-4.15%)
Volume
4,600
52 week range
2.20 - 7.37
Loading...
  • Open6.23
  • Day High6.30
  • Day Low6.23
  • Prev Close6.50
  • 52 Week High7.37
  • 52 Week High Date03/26/24
  • 52 Week Low2.20
  • 52 Week Low Date05/08/23

Key Stats

  • Market Cap148.81M
  • Shares Out24.11M
  • 10 Day Average Volume10,644.7
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change48.69

KEY STATS

  • Open6.23
  • Day High6.30
  • Day Low6.23
  • Prev Close6.50
  • 52 Week High7.37
  • 52 Week High Date03/26/24
  • 52 Week Low2.20
  • 52 Week Low Date05/08/23
  • Market Cap148.81M
  • Shares Out24.11M
  • 10 Day Average Volume10,644.7
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change48.69

RATIOS/PROFITABILITY

  • EPS (TTM)0.80
  • P/E (TTM)7.83
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cipher Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris...
Craig Mull
Chairman of the Board, Interim Chief Executive Officer
Bryan Jacobs
Chief Financial Officer
Diane Gajewczyk
Vice President - Scientific and Medical Affairs
Address
5750 Explorer Drive,, Suite 404
Mississauga, ON
L4W 0A9
Canada